TriVascular Tech Reports Third Quarter Financial Results
SANTA ROSA, Calif., Nov. 9, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (NASDAQ:TRIV), manufacturer of the Ovation® Abdominal Stent Graft platform, today reported financial results for the third quarter ended September 30, 2015.
Recent Accomplishments:
* Third quarter revenue of $9.5 million, up 20.0% over the third quarter of 2014 as reported, and 23.4% on a constant currency basis
* Third quarter gross margin of 63.5%, an increase from 57.2% in the third quarter of 2014
* 4-year Ovation Clinical data presented at the November VIVA conference
* Interim LIFE Study data highlighting clinical & economic benefits of Ovation platform also presented at VIVA conference
* Commercial roll-out of the Ovation iX™ platform initiated in the fourth quarter of 2015
Help employers find you! Check out all the jobs and post your resume.
Recent Accomplishments:
* Third quarter revenue of $9.5 million, up 20.0% over the third quarter of 2014 as reported, and 23.4% on a constant currency basis
* Third quarter gross margin of 63.5%, an increase from 57.2% in the third quarter of 2014
* 4-year Ovation Clinical data presented at the November VIVA conference
* Interim LIFE Study data highlighting clinical & economic benefits of Ovation platform also presented at VIVA conference
* Commercial roll-out of the Ovation iX™ platform initiated in the fourth quarter of 2015
Help employers find you! Check out all the jobs and post your resume.